Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 1,4-disubstituted pyridazine quinolne analogs there of and methods for treating SMN-deficiency-related conditions

1,4-disubstituted pyridazine quinolne analogs there of and methods for treating SMN-deficiency-related conditions

US Patent 11672799 · Granted Jun 13, 2023

Estimated economic value: $47,035,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pyrazolopyridine derivatives and uses thereof2025
Pyrazolopyridine derivatives and uses thereof2024
Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses ther2024
Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses ther2024
Hydroquinazoline derivatives for the treatment of a disease or disorder2024
Naphthyridinone derivatives for the treatment of a disease or disorder2024
Pyrazolopyridine derivatives and uses thereof2023
Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses ther2023
Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses ther2023
3-(5-methoxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses ther2023
1,4-disubstituted pyridazine analogs thereof and methods for treating SMN-defici2022
1,4-disubstituted pyridazine analogs thereof and methods for treating SMN-defici2022